BEUDAMED
    FDA Adverse Event Injury Summary report: N

    CERNER MILLENNIUM PHARMNET INPATIENT

    MDR report key: 2020667 · Received March 7, 2011

    Report

    Report Number
    1931259-2011-00004
    Event Type
    Injury
    Date Received
    March 7, 2011
    Date of Event
    February 15, 2011
    Report Date
    March 7, 2011
    Manufacturer
    CERNER CORP.
    Product Code
    LNX
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    MO, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 1

    CERNER DISTRIBUTED A PRIORITY REVIEW FLASH NOTIFICATION ON (B)(4) 2011 TO ALL POTENTIALLY IMPACTED CLIENT SITES. THE SOFTWARE NOTIFICATION INCLUDES A DESCRIPTION OF THE ISSUE AND A SCRIPT THAT CAN BE RUN TO DETERMINE IF THEY ARE AFFECTED BY IT. A SOFTWARE MODIFICATION WILL BE DEVELOPED ONCE THE SOURCE OF THE DEFECT IS KNOWN. A FORTHCOMING FLASH WILL COMMUNICATE THE CORRECTION FOR THIS ISSUE TO ALL SITES THAT COULD BE POTENTIALLY IMPACTED. CERNER CORPORATION WILL PROVIDE A FOLLOW-UP REPORT WHEN THE SOFTWARE MODIFICATION IS AVAILABLE.

    Description of Event or Problem · 1

    THE ISSUE INVOLVES CERNER'S SOLUTION PHARMNET INPATIENT, AND AFFECTS USERS THAT UTILIZE THE (B)(4), PHARMACY BATCH PRESCRIPTION AND REFILL WORK QUEUE FOR NEW ORDERS ENTRY, ORDER MODIFICATION, ORDER VERIFICATION, RESUMPTION, OR REFILL PROCESSING. THE SYSTEM DOES NOT PERFORM CLINICAL CHECKING OR PHARMACY ORDERS CONTAINING INGREDIENTS RELATED TO A CORRUPTED ORDER CATALOG FIELD. PT CARE COULD BE ADVERSELY AFFECTED IF CLINICIANS IGNORE THE SYSTEM ALERT THAT CLINICAL CHECKING CANNOT BE PERFORMED ON AN AFFECTED INGREDIENT. THIS ISSUE COULD RESULT IN A MEDICATION OVERDOSE THAT COULD ADVERSELY IMPACT PT CARE. CERNER HAS RECEIVED COMMUNICATION ON AN ADVERSE PT EVENT AS A RESULT OF THIS ISSUE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 CERNER MILLENNIUM PHARMNET INPATIENT SOFTWARE LNX CERNER CORP. NA

    Patients

    Seq Age Sex Outcome Treatment
    1 Hospitalization| L